Funded Tech Companies
Pleco Therapeutics
Wondering who invested in Pleco Therapeutics? Netherlands Enterprise Agency, Oost NL and Hyloris Pharmaceuticals SA joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Pleco Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Jonkerbosplein 52
Nijmegen, 6534 AB
NL
Nijmegen, 6534 AB
NL
Phone
Website
Email Address
Company Background Information
Overview
Pleco Therapeutics' mission is to demonstrate the market value and therapeutic potential of our proprietary Plecoid� products through an initial focus on treatments for orphan cancers. Thereafter we can expand our scalable product platform for the treatment of other cancers as well as neurodegenerative disorders where aberrant metal patterns have been shown to play a role. Our current pre-clinical development programs focus on the development of treatments for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, and Small-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer. Both diseases carry a poor prognosis.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/6/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ivo Timmermans
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs